Why marijuana fans should not see approval for epilepsy drug as a win for weed
- Written by Timothy Welty, Professor of Pharmacy Practice, Drake University
Roxana Gonzalez/Shutterstock.com
A Food and Drug Administration panel recommended approval of a drug made of cannabidiol on April 19 to treat two types of epilepsy. The FDA is expected to decide in June whether to accept the panel’s 13-0 recommendation to approve...
Read more: Why marijuana fans should not see approval for epilepsy drug as a win for weed